07:00 , Jul 29, 2013 |  BC Week In Review  |  Company News

AD Biotech, Quest Pharma deal

The companies formed a JV to develop immunotherapies for cancer. The companies will work together to co-develop products that combine their technologies. Quest PharmaTech said the deal gives it access to AD Biotech's antibody, protein...